FXYD3 and cancer: A study on a total of 150 resected colorectal cancer specimens measured the protein levels of FXYD3 by IHC staining and demonstrated an association of downregulated expression of FXYD3 proteins with cancer progression defined by Dukes’ staging (Widegren et al., 2009).